Literature DB >> 30763198

Oral Anticancer Therapy: Management of Drug Interactions.

Britny G Rogala1, Margaret M Charpentier1, Michelle K Nguyen2, Kaitlin M Landolf3, Lamya Hamad4, Kelly M Gaertner5.   

Abstract

Oral anticancer therapy is increasingly integrated into the care of patients with cancer. Recognition and management of drug-drug interactions (DDIs) is critical to providing efficacious and safe anticancer treatment. DDIs with QTc-prolonging agents, anticoagulants, enzyme inducers and inhibitors, antidepressants, and acid suppressants are commonly encountered with anticancer therapies. Here, we review frequently observed DDIs and outline literature-supported suggestions for their management.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30763198     DOI： 10.1200/JOP.18.00483

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  6 in total

Review 1.  Risk Factors for Aspiration Pneumonia After Receiving Liquid-Thickening Recommendations.

Authors:  Hiroaki Masuda; Rumi Ueha; Taku Sato; Takao Goto; Misaki Koyama; Akihito Yamauchi; Asako Kaneoka; Sayaka Suzuki; Tatsuya Yamasoba
Journal:  Otolaryngol Head Neck Surg       Date:  2021-09-28       Impact factor: 5.591

2.  Clinically Relevant Drug Interactions in the Cancer Setting.

Authors:  David DeRemer
Journal:  J Adv Pract Oncol       Date:  2022-05-23

Review 3.  Emerging Challenges to the Safe and Effective Use of Methadone for Cancer-Related Pain in Paediatric and Adult Patient Populations.

Authors:  Kyle P Edmonds; Ila M Saunders; Andrew Willeford; Toluwalase A Ajayi; Rabia S Atayee
Journal:  Drugs       Date:  2020-02       Impact factor: 9.546

4.  Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.

Authors:  F Ranchon; C Rioufol; H Prely; C Herledan; A G Caffin; A Baudouin; V Larbre; M Maire; V Schwiertz; N Vantard
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-29       Impact factor: 4.553

5.  Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy.

Authors:  Lauren A Marcath; Colin M Finley; Siu Fun Wong; Daniel L Hertz
Journal:  BMC Cancer       Date:  2021-03-26       Impact factor: 4.430

6.  Bradyarrhythmias in Cardio-Oncology.

Authors:  Marta Fonseca; Evaline Cheng; Duc Do; Shouvik Haldar; Shelby Kutty; Eric H Yang; Arjun K Ghosh; Avirup Guha
Journal:  South Asian J Cancer       Date:  2021-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.